Director Dealing

RNS Number : 6364A

Polarean Imaging PLC

22 January 2020

 

Polarean Imaging Plc 

("Polarean" or the "Company")

Director Dealing

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, announces that yesterday it was notified that Dr Jonathan Allis, a Non-Executive Director of the Company, purchased 337,574 Ordinary Shares of £0.00037 ("Ordinary Shares") at an average price of 29.6 pence per share on 20 January 2020.

Following this transaction, Dr Allis now holds a beneficial interest in 1,877,574 Ordinary Shares, representing approximately 1.64 per cent. of the Company's issued share capital.

Enquiries: 

Polarean Imaging plc			www.polarean.com / www.polarean-ir.com
Richard Hullihen, Chief Executive Officer				Via Walbrook PR
Richard Morgan, Chairman
SP Angel Corporate Finance LLP				Tel: [phone]
David Hignell / Soltan Tagiev (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking)
Walbrook PR	Tel: [phone] or [e-mail]
Anna Dunphy / Paul McManus		Mob: [phone]

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name:	Dr Jonathan Allis
2.	Reason for the notification
a)	Position/status:	Non-Executive Director
b)	Initial notification/Amendment:	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name:	Polarean Imaging Plc
b)	LEI:	213800DGR2BHXJ36OL37
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument: Identification code:	Ordinary shares of £0.00037 GB00BF3DT583
b)	Nature of the transaction:	Purchase of shares
c)	Price(s) and volume(s):	Price(s) Volume(s) 29.9 pence 33,444 29.9 pence 33,444 29.9 pence 33,444 29.5 pence 33,898 29.5 pence 67,796 29.5 pence 50,847 29.5 pence 50,803 29.5 pence 33,898
d)	Aggregated information: Aggregated volume: Price:	Price(s) Volume(s) 29.6 pence 337,574
e)	Date of the transaction:	20 January 2020
f)	Place of the transaction:	AIM, London Stock Exchange

 

END

 

 

DSHGZGZMVZGGGZM